Boston Life Science Venture Corp. was raised in 2003 with an investment focus on biotech and life science industries. Total fund size reached NT$ 2 billion. The fund has invested in 20 companies, 80% of which are companies located in the U.S. and Europe and 20% are companies in Taiwan. The portfolio companies engage in new drug development, drug test and manufacturing, healthcare products, medical equipment etc. Lately, the fund expanded its investments into the emerging industries such as agriculture biotech, biotech energy, biotech material and integrated digital treatment and service. The fund has disposed some of its investments with decent returns.

www.ibtm.com.tw